Investigative Ophthalmology & Visual Science Cover Image for Volume 60, Issue 9
July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Regulation of neurotransmitter release during crossover inhibition
Author Affiliations & Notes
  • Marc Andrew Meadows
    Vollum Institute, Oregon Health and Science University, Portland, Oregon, United States
  • Veeramuthu Balakrishnan
    Vollum Institute, Oregon Health and Science University, Portland, Oregon, United States
  • Xiaohan Wang
    Vollum Institute, Oregon Health and Science University, Portland, Oregon, United States
  • Henrique Von Gersdorff
    Vollum Institute, Oregon Health and Science University, Portland, Oregon, United States
  • Footnotes
    Commercial Relationships   Marc Meadows, None; Veeramuthu Balakrishnan, None; Xiaohan Wang, None; Henrique Von Gersdorff, None
  • Footnotes
    Support  NIH-NEI Grant to H.v.G. EY014043, NIH-NEI Training Grant to Casey Eye Institute 5T32EY023211-05 (MPI) and 4T32EY023211-04 (MPI)
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 547. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Marc Andrew Meadows, Veeramuthu Balakrishnan, Xiaohan Wang, Henrique Von Gersdorff; Regulation of neurotransmitter release during crossover inhibition. Invest. Ophthalmol. Vis. Sci. 2019;60(9):547.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : AII amacrine cells (AIIs) receive excitation at their distal arboreal dendrites from rod bipolar cell glutamatergic terminals during night and from electrical synapses with ON cone bipolar cells during daytime. This excitation is translated by AIIs into graded synaptic release of inhibitory glycine from their proximal dendritic lobules onto OFF cone bipolar cell (OFF-BC) terminals, termed crossover inhibition. AIIs operate across a wide range of light intensities from night to day. This is partially attributed to the functional modulation of homologous AII-AII gap junction coupling— dependent on the second messenger cAMP. Since synaptic potentiation is one of the many cellular processes that are mediated by cAMP, we examined the role of cAMP at the AII to OFF-BC inhibitory synapse.

Methods : Presynaptic capacitance (Cm) recordings using the “sine +DC” method in whole-cell voltage clamp were performed to measure net vesicle fusion (exocytosis) in AIIs. Exocytosis was evoked with a 70 mV, 100 ms depolarizing pulse (Vhold = -80 mV). In between the step depolarization two voltage-clamped sine waves (2kHz; 30mV peak to peak) were applied to calculate time-resolved Cm. Whole-cell inhibitory postsynaptic currents were recorded in OFF-BCs (Vhold= -70mV). Electrophysiological recordings were performed at 33°C using Cs-based internal solutions. Results displayed as mean ± SEM.

Results : Cm jumps were recorded with 1 mM cAMP in the patch pipette solution. Unlike our controls, Cm jumps increased on average after the dialysis of cAMP for 4 min (1 min: 47.3 ± 4.9 fF and at 4 min: 73.9 ± 7.53 fF; n=20). Potentiation was blocked using 1µM HJC 0350, a selective EPAC antagonist. Cm jumps were enhanced by increasing intracellular cAMP with 25 µM forskolin. Forskolin also increased the frequency of glycinergic sIPSCs in OFF-BCs.

Conclusions : Our findings suggest that cAMP performs dual roles in the AII through different molecular pathways. Previous reports show that a cAMP/PKA pathway regulates coupling in the distal dendritic compartment; however, our study indicates that cAMP also interacts with EPAC in the proximal dendritic compartment (the lobular appendages). This molecular mechanism may potentiate glycine release from AIIs by modulating proteins involved with vesicle fusion (e.g. SNARE, RIMs, or MUNC13), and may provide a way for this synapse to enhance the tonic inhibition of OFF-BCs across a broader range of light intensities.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×